Stockreport

Guardant Health Announces Launch of the LUNAR Assay for Detection of Early-Stage Cancer and Recurrence to Academic and Biopharmaceutical Researchers

Guardant Health, Inc.  (GH) 
Last guardant health, inc. earnings: 2/24 04:03 pm Check Earnings Report
PDF REDWOOD CITY, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- The LUNAR assay, a new blood-based assay intended to detect early-stage cancer and recurrence of disease, is no [Read more]